Molecular cloning and characterization of prokineticin receptors.

Biochim Biophys Acta

Molecular Medicine Laboratories, Institute for Drug Discovery Research, Yamanouchi Pharmaceutical Co., Ltd., 21 Miyukigaoka, Ibaraki 305-8585, Tsukuba, Japan.

Published: December 2002

Recent studies have identified two novel biofunctional proteins, termed prokineticin 1/EG-VEGF and prokineticin 2, which were mammalian homologues of mamba MIT1 and frog Bv8. Prokineticins have been demonstrated to exert their physiological functions through G-protein coupled receptors (GPCRs). In this study, we report the molecular identification of two endogenous prokineticin receptors, designated PK-R1 and PK-R2, through a search of the human genomic DNA database. PK-R1, locating in chromosome 2, and PK-R2, locating in chromosome 20p13, shared 87% homology, which was an extremely high value among known GPCRs. In functional assays, mammalian cells expressing PK-Rs responded to prokineticins in a concentration-dependent manner. Tissue distribution analysis revealed that expression of PK-R1 was observed in the testis, medulla oblongata, skeletal muscle and skin, while that of PK-R2 showed preferential expression in the central nervous system. The tissue distribution of PK-Rs reported in this paper suggests that the prokineticins play multifunctional roles in vivo.

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0167-4781(02)00546-8DOI Listing

Publication Analysis

Top Keywords

prokineticin receptors
8
locating chromosome
8
tissue distribution
8
molecular cloning
4
cloning characterization
4
prokineticin
4
characterization prokineticin
4
receptors studies
4
studies identified
4
identified novel
4

Similar Publications

Genetic Polymorphisms of Prokineticins and Prokineticin Receptors Associated with Human Disease.

Life (Basel)

October 2024

Department of Biochemical Sciences "A. Rossi Fanelli", CNR-Institute of Molecular Biology and Pathology, Sapienza University of Rome, Piazzale Aldo Moro 5, I-00185 Rome, Italy.

Article Synopsis
  • * Genetic variations (polymorphisms) in the PKs and PKR genes have been associated with conditions like infertility, neuroendocrine disorders, Hirschsprung's syndrome, central precocious puberty, and Kallmann syndrome.
  • * The study aims to highlight how these genetic variations impact disease development and outcomes, positioning the PK system as a potential target for therapy and a marker for diagnosis in related health issues.
View Article and Find Full Text PDF
Article Synopsis
  • The suprachiasmatic nucleus (SCN) in the hypothalamus is the central control hub for circadian rhythms in mammals, producing various neurotransmitters.
  • Researchers confirmed the presence of β-adrenergic receptors in the SCN and examined their effects on energy signaling through cAMP-regulated elements.
  • The study's findings suggest that stress-related increases in adrenaline can impact circadian functions and may help explain side effects of β-blockers used for hypertension.
View Article and Find Full Text PDF

Prokineticin 2 (PK2) binds to prokineticin receptor 1 and prokineticin receptor 2 (PKR1 and PKR2, respectively), two G protein-coupled receptors (GPCRs) that can mediate multiple signalling pathways by promoting the elevation of intracellular calcium and cAMP levels, phosphorylation of Akt and activation of ERK and STAT3. This work aims to evidence the conservation of protein sequence and the mechanism of PK2 binding to PKR1 to use the zebrafish model for the identification of new drugs as targets of prokineticin receptors. To this end, we first demonstrated that the zebrafish genes pk2 and pkr1 are phylogenetically related to orthologous mammalian genes by constructing evolutionary trees and performing syntenic analyses.

View Article and Find Full Text PDF

The prokineticin system plays a role in hypothalamic neurons in the control of energy homeostasis. Prokineticin receptors (PKR1 and PKR2), like other G-protein-coupled receptors (GPCRs) are involved in the regulation of energy intake and expenditure and are modulated by the accessory membrane protein 2 of the melanocortin receptor (MRAP2). The aim of this work is to characterise the interaction and regulation of the non-melanocortin receptor PKR1 by MRAP2a in zebrafish (zMRAP2a) in order to use zebrafish as a model for the development of drugs targeting accessory proteins that can alter the localisation and activity of GPCRs.

View Article and Find Full Text PDF

Aim: The hypothesis of this study is to determine the effects of intracerebroventricular (icv) prokineticin 2 infusion on food consumption and body weight and to elucidate whether it has effects on energy expenditure via the hypothalamus-pituitary-thyroid (HPT) axis in adipose tissue.

Material And Methods: A total of 40 rats were used in the study and 4 groups were established: Control, Sham, Prokineticin 1.5 and Prokineticin 4.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!